Immix Depreciation vs Change In Cash Analysis

IMMX Stock  USD 2.17  0.05  2.25%   
Immix Biopharma financial indicator trend analysis is infinitely more than just investigating Immix Biopharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immix Biopharma is a good investment. Please check the relationship between Immix Biopharma Depreciation and its Change In Cash accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.

Depreciation vs Change In Cash

JavaScript chart by amCharts 3.21.152014201620182020202220241K1.5K2K2.5K3K3.5K4K4.5K5K5.5K -4M-2M02M4M6M8M10M12M14M16M18M
JavaScript chart by amCharts 3.21.15Depreciationtotal: 22.9KChange In Cashtotal: 22.4M

Depreciation vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immix Biopharma Depreciation account and Change In Cash. At this time, the significance of the direction appears to have weak relationship.
DepreciationChange In CashDiversified AwayDepreciationChange In CashDiversified Away100%
The correlation between Immix Biopharma's Depreciation and Change In Cash is 0.36. Overlapping area represents the amount of variation of Depreciation that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Immix Biopharma, assuming nothing else is changed. The correlation between historical values of Immix Biopharma's Depreciation and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Depreciation of Immix Biopharma are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Depreciation i.e., Immix Biopharma's Depreciation and Change In Cash go up and down completely randomly.

Correlation Coefficient

0.36
Relationship DirectionPositive 
Relationship StrengthVery Weak

Depreciation

Depreciation indicates how much of Immix Biopharma value has been used up. For tax purposes Immix Biopharma can deduct the cost of the tangible assets it purchases as business expenses. However, Immix Biopharma must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.

Change In Cash

Most indicators from Immix Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immix Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immix Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.At this time, Immix Biopharma's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 28.8 M in 2024, whereas Tax Provision is likely to drop slightly above 12.5 K in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses1.4M8.2M16.1M16.9M
Cost Of Revenue2.5K2.1K5.5K3.0K

Immix Biopharma fundamental ratios Correlations

-0.970.63-0.831.00.970.52-0.98-0.930.541.00.61.00.570.98-0.970.920.99-0.831.00.52-0.971.00.981.0-0.97
-0.97-0.690.87-0.97-0.99-0.560.990.96-0.59-0.97-0.64-0.97-0.62-0.951.0-0.92-0.970.86-0.97-0.561.0-0.97-0.95-0.971.0
0.63-0.69-0.270.570.650.89-0.69-0.860.910.60.930.60.940.76-0.710.720.7-0.260.570.89-0.690.630.730.57-0.69
-0.830.87-0.27-0.88-0.88-0.150.850.7-0.16-0.85-0.23-0.85-0.2-0.710.85-0.72-0.771.0-0.88-0.150.87-0.83-0.73-0.880.87
1.0-0.970.57-0.880.980.46-0.98-0.90.481.00.541.00.510.95-0.970.90.98-0.881.00.46-0.971.00.961.0-0.97
0.97-0.990.65-0.880.980.56-1.0-0.940.580.980.640.980.610.94-1.00.880.95-0.890.980.56-0.990.970.940.98-0.99
0.52-0.560.89-0.150.460.56-0.6-0.751.00.50.990.50.990.67-0.60.510.57-0.160.471.0-0.560.520.620.45-0.56
-0.980.99-0.690.85-0.98-1.0-0.60.96-0.62-0.98-0.67-0.98-0.64-0.961.0-0.9-0.970.86-0.98-0.60.99-0.98-0.96-0.980.99
-0.930.96-0.860.7-0.9-0.94-0.750.96-0.77-0.92-0.82-0.92-0.81-0.960.97-0.92-0.950.7-0.9-0.750.96-0.93-0.95-0.90.96
0.54-0.590.91-0.160.480.581.0-0.62-0.770.521.00.520.990.68-0.620.540.59-0.180.491.0-0.590.540.640.47-0.59
1.0-0.970.6-0.851.00.980.5-0.98-0.920.520.581.00.550.96-0.970.90.98-0.861.00.5-0.971.00.971.0-0.97
0.6-0.640.93-0.230.540.640.99-0.67-0.821.00.580.580.990.73-0.680.60.65-0.240.550.99-0.640.60.690.53-0.64
1.0-0.970.6-0.851.00.980.5-0.98-0.920.521.00.580.550.96-0.970.90.98-0.861.00.5-0.971.00.971.0-0.97
0.57-0.620.94-0.20.510.610.99-0.64-0.810.990.550.990.550.72-0.650.610.63-0.20.520.99-0.620.570.680.51-0.62
0.98-0.950.76-0.710.950.940.67-0.96-0.960.680.960.730.960.72-0.960.940.99-0.710.950.67-0.950.981.00.95-0.95
-0.971.0-0.710.85-0.97-1.0-0.61.00.97-0.62-0.97-0.68-0.97-0.65-0.96-0.92-0.970.85-0.97-0.61.0-0.97-0.96-0.971.0
0.92-0.920.72-0.720.90.880.51-0.9-0.920.540.90.60.90.610.94-0.920.96-0.690.890.51-0.920.920.950.91-0.92
0.99-0.970.7-0.770.980.950.57-0.97-0.950.590.980.650.980.630.99-0.970.96-0.770.970.57-0.970.991.00.98-0.97
-0.830.86-0.261.0-0.88-0.89-0.160.860.7-0.18-0.86-0.24-0.86-0.2-0.710.85-0.69-0.77-0.88-0.160.86-0.84-0.72-0.880.86
1.0-0.970.57-0.881.00.980.47-0.98-0.90.491.00.551.00.520.95-0.970.890.97-0.880.47-0.971.00.961.0-0.97
0.52-0.560.89-0.150.460.561.0-0.6-0.751.00.50.990.50.990.67-0.60.510.57-0.160.47-0.560.520.620.45-0.56
-0.971.0-0.690.87-0.97-0.99-0.560.990.96-0.59-0.97-0.64-0.97-0.62-0.951.0-0.92-0.970.86-0.97-0.56-0.97-0.95-0.971.0
1.0-0.970.63-0.831.00.970.52-0.98-0.930.541.00.61.00.570.98-0.970.920.99-0.841.00.52-0.970.981.0-0.97
0.98-0.950.73-0.730.960.940.62-0.96-0.950.640.970.690.970.681.0-0.960.951.0-0.720.960.62-0.950.980.96-0.95
1.0-0.970.57-0.881.00.980.45-0.98-0.90.471.00.531.00.510.95-0.970.910.98-0.881.00.45-0.971.00.96-0.97
-0.971.0-0.690.87-0.97-0.99-0.560.990.96-0.59-0.97-0.64-0.97-0.62-0.951.0-0.92-0.970.86-0.97-0.561.0-0.97-0.95-0.97
Click cells to compare fundamentals

Immix Biopharma Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…